Similarly, ERG+ human PCa (particularly those with concurrent PTEN loss) display reduced AR pathway activation, reduced luminal signatures and elevated GEMM-derived IM signatures, as measured transcriptionally in single-cell and bulk RNA-seq datasets (Fig. 5a,b). The gene discussed is PTEN; the disease is posterior cortical atrophy.